NO20030925D0 - Gem-substituted alpha V beta 3 integrin antagonists - Google Patents
Gem-substituted alpha V beta 3 integrin antagonistsInfo
- Publication number
- NO20030925D0 NO20030925D0 NO20030925A NO20030925A NO20030925D0 NO 20030925 D0 NO20030925 D0 NO 20030925D0 NO 20030925 A NO20030925 A NO 20030925A NO 20030925 A NO20030925 A NO 20030925A NO 20030925 D0 NO20030925 D0 NO 20030925D0
- Authority
- NO
- Norway
- Prior art keywords
- gem
- beta
- integrin antagonists
- substituted alpha
- alpha
- Prior art date
Links
- 102000008607 Integrin beta3 Human genes 0.000 title 1
- 108010020950 Integrin beta3 Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22918600P | 2000-08-30 | 2000-08-30 | |
| PCT/US2001/026963 WO2002018340A1 (en) | 2000-08-30 | 2001-08-29 | GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030925D0 true NO20030925D0 (en) | 2003-02-27 |
| NO20030925L NO20030925L (en) | 2003-04-24 |
Family
ID=22860154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030925A NO20030925L (en) | 2000-08-30 | 2003-02-27 | Gem-substituted <alfa> v <beta> 3-integrin antagonists |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1313705A1 (en) |
| JP (1) | JP2004510708A (en) |
| KR (1) | KR20030027106A (en) |
| CN (1) | CN1471512A (en) |
| AU (1) | AU2001288515A1 (en) |
| BR (1) | BR0113671A (en) |
| CA (1) | CA2419699A1 (en) |
| CZ (1) | CZ2003459A3 (en) |
| EA (1) | EA200300226A1 (en) |
| IL (1) | IL154496A0 (en) |
| MX (1) | MXPA03001759A (en) |
| NO (1) | NO20030925L (en) |
| NZ (1) | NZ524159A (en) |
| PL (1) | PL365729A1 (en) |
| WO (1) | WO2002018340A1 (en) |
| ZA (1) | ZA200301162B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060056377A (en) * | 2003-08-13 | 2006-05-24 | 카이론 코포레이션 | UBS-3 inhibitor and its use |
| WO2006043930A1 (en) * | 2004-10-14 | 2006-04-27 | Pharmacia Corporation | Biphenyl integrin antagonists |
| CN101880270B (en) * | 2009-05-07 | 2012-10-03 | 上海华升生物科技有限公司 | Method for preparing 1,1-cyclopropanedimethyl cyclicsulfite |
| RS64535B1 (en) | 2013-09-24 | 2023-09-29 | Fujifilm Corp | Pharmaceutical composition of a nitrogen-containing compound or salt thereof, or metal complex thereof |
| RS66976B1 (en) * | 2019-10-16 | 2025-07-31 | Morphic Therapeutic Inc | INHIBITION OF HUMAN INTEGRIN ALPHA4BETA7 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| CN1209063A (en) * | 1995-12-29 | 1999-02-24 | 史密丝克莱恩比彻姆公司 | Vitronection receptor antagonists |
| US5919792A (en) * | 1996-10-30 | 1999-07-06 | Merck & Co., Inc. | Integrin antagonists |
| JP2002510328A (en) * | 1997-07-25 | 2002-04-02 | スミスクライン・ビーチャム・コーポレイション | Vitronectin receptor antagonist |
| CN1273529A (en) * | 1997-09-24 | 2000-11-15 | 史密丝克莱恩比彻姆公司 | Vitronection receptor antagonist |
-
2001
- 2001-08-29 EA EA200300226A patent/EA200300226A1/en unknown
- 2001-08-29 JP JP2002523458A patent/JP2004510708A/en not_active Withdrawn
- 2001-08-29 EP EP01968257A patent/EP1313705A1/en not_active Withdrawn
- 2001-08-29 CA CA002419699A patent/CA2419699A1/en not_active Abandoned
- 2001-08-29 NZ NZ524159A patent/NZ524159A/en unknown
- 2001-08-29 BR BR0113671-2A patent/BR0113671A/en not_active IP Right Cessation
- 2001-08-29 KR KR10-2003-7003099A patent/KR20030027106A/en not_active Withdrawn
- 2001-08-29 MX MXPA03001759A patent/MXPA03001759A/en not_active Application Discontinuation
- 2001-08-29 AU AU2001288515A patent/AU2001288515A1/en not_active Abandoned
- 2001-08-29 IL IL15449601A patent/IL154496A0/en unknown
- 2001-08-29 WO PCT/US2001/026963 patent/WO2002018340A1/en not_active Ceased
- 2001-08-29 CN CNA018181082A patent/CN1471512A/en active Pending
- 2001-08-29 PL PL01365729A patent/PL365729A1/en not_active Application Discontinuation
- 2001-08-29 CZ CZ2003459A patent/CZ2003459A3/en unknown
-
2003
- 2003-02-12 ZA ZA200301162A patent/ZA200301162B/en unknown
- 2003-02-27 NO NO20030925A patent/NO20030925L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1471512A (en) | 2004-01-28 |
| NO20030925L (en) | 2003-04-24 |
| KR20030027106A (en) | 2003-04-03 |
| IL154496A0 (en) | 2003-09-17 |
| JP2004510708A (en) | 2004-04-08 |
| ZA200301162B (en) | 2004-05-12 |
| EA200300226A1 (en) | 2003-10-30 |
| WO2002018340A1 (en) | 2002-03-07 |
| BR0113671A (en) | 2004-01-06 |
| EP1313705A1 (en) | 2003-05-28 |
| NZ524159A (en) | 2004-08-27 |
| MXPA03001759A (en) | 2004-11-01 |
| CA2419699A1 (en) | 2002-03-07 |
| PL365729A1 (en) | 2005-01-10 |
| CZ2003459A3 (en) | 2003-09-17 |
| AU2001288515A1 (en) | 2002-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE232200T1 (en) | NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS | |
| NO20031268D0 (en) | 4 Quinazolines | |
| NO20032612D0 (en) | CXCR3 antagonists | |
| ATE437585T1 (en) | ZIPPER | |
| EE200000171A (en) | New NPY antagonists | |
| EP1229910A4 (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| DE60030831D1 (en) | Zipper | |
| NO20000542L (en) | Endothelin antagonists | |
| NO20004503D0 (en) | Vitronectin receptor antagonists | |
| NO20003694D0 (en) | VLA-4 antagonists | |
| NO20013013L (en) | <Alpha> v <beta> 6-integrin | |
| NO20031267L (en) | 4 Quinazolines | |
| DE60009219D1 (en) | Linear zipper | |
| NO20015237L (en) | Integrin antagonists | |
| NO20030925D0 (en) | Gem-substituted alpha V beta 3 integrin antagonists | |
| NO20016341D0 (en) | Inhibitors for the integrin <alfa> v <beta> 6 | |
| EP1192168A4 (en) | GALECTINE 11 | |
| NO20010620D0 (en) | Vitronectin receptor antagonists | |
| NO20020886D0 (en) | Novel integrin <alfa> v <beta> 3 inhibitors | |
| ITAT990002U1 (en) | "MILLENIUM DUE" PROJECT | |
| ITRC20000003A1 (en) | "BI ALA - IN" | |
| ITRC20000003V0 (en) | "BI ALA - IN" | |
| PT9613T (en) | VYSOR 3 D | |
| SE9901602D0 (en) | Jet-thresh 2000 | |
| SE9900910D0 (en) | FreezeBox 2000 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |